TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $8 to $3.
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $8 to $3.